MedBud has been incorporated as a non-profit organisation, with Dr. Tahzid Ahsan (Specialist Psychiatrist) joining as medical director Announcement on X/Twitter

Back to Aurora® or All Oil Concentrates

Details provided are based upon best-known information made available to MedBud, please reconfirm with your pharmacy. This product was last updated:
MedBud typically only updates products when availability changes, or new information is provided. An availability status from several months ago can still be valid when a product remains in/out of stock, or has been discontinued.

Terpene Profile (Comparative Values)

Alpha-Pinene37.97%Pine/Sharp
Beta-Pinene10.13%Pine/Herbal
Myrcene10.13%Herbal/Musk
Caryophyllene25.32%Pepper/Spice
Ocimene7.59%Herbal/Sweet
Nerolidol8.86%Woody/Floral

MedBud currently tracks 16 common terpenes, more will be added.

Dosing Look-Up Table (Estimated)

0.01/g2.5/mg THC0.5/mg CBD
0.05/g12.5/mg THC2.5/mg CBD
0.1/g25/mg THC5/mg CBD
0.15/g37.5/mg THC7.5/mg CBD
0.2/g50/mg THC10/mg CBD
0.25/g62.5/mg THC12.5/mg CBD
0.3/g75/mg THC15/mg CBD
/gCalculate THCCalculate CBD

Please note values above are based on registered THC/CBD percentages, subject to ±10% allowed variance. Values provided are 'best case', losses to air during vaporisation or combustion will always occur.

Medication Details

Brand
🇩🇰 Aurora®
Designation
T25
Chemotype
Type I: High THC
Carrier Oil
Medium-Chain Triglycerides
THC Potential Range (±10%)
22.5-27.5/mg
CBD Potential Range (±10%)
4.5-5.5/mg
Cultivated or Packaged in
Flag of Denmark Denmark
Imported by
United Kingdom IPS Pharma
Imported as
Schedule I: Raw Material
Formulated by
United Kingdom IPS Pharma

Stock Availability

We provide stock/pharmacy information only for use by medical cannabis patients, clinicians and pharmacists*.

Best-Known Status: Awaiting ETA

We try to ascertain stock status strictly based on the importer/distributor supplying pharmacies. Availability at individual pharmacies will differ.

*Cannabis is a controlled-substance and can only be legally dispensed upon submission of a valid prescription from a prescribing clinic, ordinarily listed.

Main Partner Pharmacy

Pharmacy Distributor

Dispensing Patient Pharmacies

Project Twenty21

Available on T21, a research project offering participating patients several discounted medications:

Participating Pharmacies:

Grow Access Project

Available on GAP, an access scheme for veterans and recipients of means-tested benefits:

Participating Pharmacy:
Product DescriptionPatient Reviews

About L.A. Confidential

LACSativa

L.A. Confidential's powerful laziness is often accompanied by sleep an hour or two after consumption. Negative effects may include cotton mouth, dry eyes, paranoia, dizziness, or headaches, especially with higher doses.

Dutch Flag Dutch Bred, American Flag American Genetics, Afghani Flag Afghani Genetics

L.A. Confidential is a pure Indica strain that has won multiple awards, including the 2006 High Times Strain of the Year.

The high of this pine-scented strain begins by numbing the body, inducing a state known as "couch-lock." Users experiencing couch-lock often feel waves of relaxing and calming euphoria and, occasionally, cerebral effects.

Although this is a pure Indica strain, a few users find its cerebral effects bordering on the psychedelic. It may also be thought-provoking and mood-lifting. L.A. Confidential's powerful laziness is often accompanied by sleep an hour or two after consumption. Negative effects may include cotton mouth, dry eyes, paranoia, dizziness, or headaches, especially with higher doses.

Recommended for evening and nighttime use, this strain may relieve insomnia though some find it makes them tired without actually bringing on sleep. The strong Indica effects make L.A. Confidential suitable for easing chronic aches and pains. Users often choose the strain to help them deal with stress and anxiety, and some patients use it to induce appetite or calm nausea.

L.A. Confidential is the child of DNA Genetics Seeds and is a cross of O.G. LA Affie and a pure landrace Afghani Indica.

Description provided by Wikileaf.

Information provided could come from a third-party source, and likely does not accurately reflect characteristics of the medication we're associating it with - we primarily provide these descriptions for those interested in strain lineage and history, which could also be inaccurate. Any information which could be taken as medical advice should be strictly disregarded. Please consult your doctor regarding the suitability of medications for your condition(s).

🇩🇰 About Aurora Europe GmbH

Aurora® Logo

Aurora Cannabis is a leading integrated cannabis company with a robust network of subsidiaries and strategic partnerships. With state-of-the-art production facilities and exclusive sales agreements in the European Union and beyond.

Aurora Cannabis is a leading integrated cannabis company with a robust network of subsidiaries and strategic partnerships. With state-of-the-art production facilities and exclusive sales agreements in the European Union and beyond, Aurora operates around the globe pursuing new and emerging cannabis markets. Through the Company’s unparalleled pace of execution and commitment to innovation, Aurora has become one of the world’s largest and fastest growing cannabis companies that continues to elevate and challenge industry standards.

Aurora has three operational facilities in Canada (Aurora Sky, Aurora Vie, and Aurora Mountain) plus two new facilities projected to be operational by the end of 2019, including a 1,000,000-square-foot (93,000 m2) facility under construction in Odense, Denmark. Construction on the Nordic 2 project in Denmark was stopped in November 2019 when the company's stock dropped to a two year low. The Aurora Sun project in Alberta was put on a temporary hold. These decisions would lead to a savings of $190 million.

Aurora Mountain was Aurora's first facility, completed in 2015. It is a 55,200-square-foot (5,130 m2) production facility in Mountain View County. Aurora Vie is a 40,000-square-foot (3,700 m2), fully licensed, indoor production facility in Pointe-Claire, Quebec. It was the second licensed producer in Quebec, and was acquired in 2017 for $7 million when it was about 80% complete. In 2017, Aurora Cannabis began construction of an automated 800,000-square-foot (74,000 m2) plant in Alberta that it said would be capable of producing 100,000 kilograms of cannabis annually. The land is part of the acreage owned by the Edmonton International Airport. In 2021, Aurora shuttered its Aurora Polaris facility in Edmonton.

  Information provided is partially -sourced and may be outdated or otherwise incorrect. Please report any inaccuracies found by email.

NHS LogoFurther National Health-Service Information on Cannabis-Based Products for Medicinal Use (CBPMs)